A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
NuCana plc
GlaxoSmithKline
Pharmacyclics LLC.
Memorial Sloan Kettering Cancer Center